obväz hydroaktívny chladivý alnanogel
alegro medical christiane jacob e.k. fabrikstrasse 51 66424 homburg nemecko -
obväz hydroaktívny chladivý alnanogel
alegro medical christiane jacob e.k. fabrikstrasse 51 66424 homburg nemecko -
krytie hydroaktívne sterilné l-mesitran hydro
theo manufacturing bv capucijnenstraat 71 6211 rp maastricht holandsko -
masť hydroaktívna antibakteriálna l-mesitran ointment
theo manufacturing bv capucijnenstraat 71 6211 rp maastricht holandsko -
masť hydroaktívna antibakteriálna l-mesitran ointment
theo manufacturing bv capucijnenstraat 71 6211 rp maastricht holandsko -
krytie na rany hydroaktívne cutimed sorbion sorbact
bsn medical gmbh quickbornstrasse 24 20253 hamburg nemecko -
krytie na rany hydroaktívne cutimed sorbion sorbact
bsn medical gmbh quickbornstrasse 24 20253 hamburg nemecko -
roztok implantovateľný juvederm hydrate
allergan (corneal industrie, sas) route de promery, zone artisanale de pré-mairy 743 70 pringy francúzsko -
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, typ 2 - lieky používané pri cukrovke - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trojlôžkových kombinovaná liečba) ako doplnok stravy a cvičenia pacientov nedostatočne kontrolované na ich maximálna tolerovaná dávka metformín a sulfonylmocoviny. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
biresp spiromax
teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - drogy obštrukčnej choroby dýchacích ciest, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).